EP1.18-19 Patients with Unresectable Stage III Non-Small Cell Lung Cancer Eligible to Receive Durvalumab in Clinical Practice

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

14

Issue :

10, Number 10 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs51496353

Full Text :

https://doi.org/10.1016/j.jtho.2019.08.2464